1
![Omrix Biopharmaceuticals]()
![Omrix Biopharmaceuticals]()
![Omrix Biopharmaceuticals]()
Omrix Biopharmaceuticals
Leadership team
Robert Taub (Founder)
Products/ Services
Biotechnology, Health Care, Manufacturing, Medical
Number of Employees
500 - 1000
Headquarters
Qiryat Ono, Tel Aviv, Israel
Established
1995
Traded as
NASDAQ:OMRI
Overview
Location
Summary
Omrix Biopharmaceuticals, Inc., formerly known as OMP Therapeutics, Inc., is a biopharmaceutical company specializing in the development and commercialization of highly innovative, life-saving therapies for difficult-to-treat conditions in the fields of hematology, immunology and oncology.
History
Omrix Biopharmaceuticals was founded in 2000 as OMP Therapeutics, with the goal of developing innovative treatments for difficult-to-treat conditions. In 2011, the company was acquired by Johnson & Johnson and became Omrix Biopharmaceuticals. Over the years, the company has developed a number of biopharmaceutical products, including a recombinant collagen sealant and a human thrombin product for the treatment of bleeding. The company has also developed a number of vaccines, including a vaccination for typhoid.
Mission
Our mission is to develop and commercialize innovative, life-saving treatments in the fields of hematology, immunology and oncology, with the goal of giving physicians and patients access to therapies that provide superior clinical outcomes. We strive to be the trusted partner of choice for health care providers and patients by providing the highest quality products, the most advanced medical treatments, and services that help facilitate better patient care.
Vision
It is our aim to develop and commercialize cutting-edge treatments that provide superior clinical outcomes, and to provide physicians and patients with access to the most advanced treatments available. We strive to create a world in which treatments are accessible, affordable, and effective in improving the quality of care for patients.
Key Team
Robert Taub (Founder)
Recognition and Awards
Omrix Biopharmaceuticals has been awarded numerous awards and honors, including the Johnson & Johnson Innovation Recognition Award in 2006, the Wall Street Journal Top 25 Innovative Companies in 2007, and the World Economic Forum's Technology Pioneer Award in 2008.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Robert Taub (Founder)
Products/ Services
Biotechnology, Health Care, Manufacturing, Medical
Number of Employees
500 - 1000
Headquarters
Qiryat Ono, Tel Aviv, Israel
Established
1995
Traded as
NASDAQ:OMRI